Skip to main content

Advertisement

Log in

Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium

  • Original Paper
  • Published:
Cell and Tissue Banking Aims and scope Submit manuscript

Abstract

Mesenchymal stem cells (MSCs) are multipotent adult stem cells that have an immunosuppressive effect. The biological stability of MSCs in serum-free medium during long-term culture in vitro has not been elucidated clearly. The morphology, immunophenotype and multi-lineage potential were analyzed at passages 3, 5, 10, 15, 20, and 25 (P3, P5, P10, P15, P20, and P25, respectively). The cell cycle distribution, apoptosis, and karyotype of human umbilical cord-derived (hUC)-MSCs were analyzed at P3, P5, P10, P15, P20, and P25. From P3 to P25, the three defining biological properties of hUC-MSCs [adherence to plastic, specific surface antigen expression, multipotent differentiation potential] met the standards proposed by the International Society for Cellular Therapy for definition of MSCs. The cell cycle distribution analysis at the P25 showed that the percentage of cells at G0/G1 was increased, compared with the cells at P3 (P < 0.05). Cells at P25 displayed an increase in the apoptosis rate (to 183 %), compared to those at P3 (P < 0.01). Within subculture generations 3–20 (P3–P20), the differences between the cell apoptotic rates were not statistically significant (P > 0.05). There were no detectable chromosome eliminations, displacements, or chromosomal imbalances, as assessed by the karyotyping guidelines of the International System for Human Cytogenetic Nomenclature (ISCN, 2009). Long-term culture affects the biological stability of MSCs in serum-free MesenCult-XF medium. MSCs can be expanded up to the 25th passage without chromosomal changes by G-band. The best biological activity period and stability appeared between the third to 20th generations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Ahrari I, Purhabibi Zarandi N, Khosravi Maharlooei M et al (2013) Adipose tissue derived multipotent mesenchymal stromal cells can be isolated using serum-free media. Iran Red Crescent Med J 15(4):324–329

    Article  PubMed Central  PubMed  Google Scholar 

  • Bobis S, Jarocha D, Majka M (2006) Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 44:215–230

    CAS  PubMed  Google Scholar 

  • Castrechini NM, Murthi P, Gude NM et al (2010) Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche. Placenta 31:203–212

    Article  CAS  PubMed  Google Scholar 

  • Corotchi MC, Popa MA, Remes A, Sima LE, Gussi I, Lupu Plesu M (2013) Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton’s jelly-derived mesenchymal stem cells. Stem Cell Res Ther 4:81

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ding DC, Chou HL, Hung WT, Liu HW, Chu TY (2013) Human adipose-derived stem cells cultured in keratinocyte serum free medium: donor’s age does not affect the proliferation and differentiation capacities. J Biomed Sci 20(1):59

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317

    Article  CAS  PubMed  Google Scholar 

  • Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267–274

    CAS  PubMed  Google Scholar 

  • Jin ES, Min J, Jeon SR, Choi KH, Jeong JH (2013) Analysis of molecular expression in adipose tissue-derived mesenchymal stem cells: prospects for use in the treatment of intervertebral disc degeneration. J Korean Neurosurg Soc 53:207–212

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Passeri S, Nocchi F, Lamanna R et al (2009) Isolation and expansion of equine umbilical cord-derived matrix cells (EUCMCs). Cell Biol Int 33:100–105

    Article  CAS  PubMed  Google Scholar 

  • Patrikoski Mimmi, Juntunen Miia, Boucher Shayne et al (2013) Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells. Stem Cell Res Ther 4(2):27

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Redaelli S, Bentivegna A, Foudah D et al (2012) From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther 3:47

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sensebe L (2008) Clinical grade production of mesenchymal stem cells. Biomed Mater Eng 18:S3–S10

    CAS  PubMed  Google Scholar 

  • Seshareddy K, Troyer D, Weiss ML (2008) Method to isolate mesenchymal-like cells from Wharton’s Jelly of umbilical cord. Methods Cell Biol 86:101–119

    Article  CAS  PubMed  Google Scholar 

  • Shaffer L, Slovak ML, Campbell LJ (2009) ISCN 2009, an international system for human cytogenetic nomenclature

  • Shin S, Sun Y, Liu Y et al (2007) Whole genome analysis of human neural stem cells derived from embryonic stem cells and stem and progenitor cells isolated from fetal tissue. Stem Cells 25:1298–1306

    Article  CAS  PubMed  Google Scholar 

  • Shujia J, Haider HK, Idris NM, Lu G, Ashraf M (2008) Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res 77:525–533

    Article  CAS  PubMed  Google Scholar 

  • Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462–471

    Article  PubMed  Google Scholar 

  • Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484–1490

    Article  CAS  PubMed  Google Scholar 

  • Trivanovic D, Kocic J, Mojsilovic S et al (2013) Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton’s jelly. Srp Arh Celok Lek 141:178–186

    Article  PubMed  Google Scholar 

  • Yang LM, Bi LQ, Jiang WH (2008) Biological characterization of human umbilical cord mesenchymal stem cells following tissue mass cell culture. J Clin Rehabil Tissue Eng Res 12:9221–9225

    CAS  Google Scholar 

  • Zeng Q, Shi MA, Qian P (2008) Efficient derivation of mesenchymal stem cells and neural precursor cells from human embryonic stem cells through teratoma formation. Prog Biochem Biophys 35:1417–1424

    Google Scholar 

  • Zhou P, Li D, Chen GH, Wang Y (2013) Serum-free culture of umbilical cord mesenchymal stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21(5):1256–1260

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Zhu.

Additional information

Gecai Chen and Aihuan Yue have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, G., Yue, A., Ruan, Z. et al. Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium. Cell Tissue Bank 15, 513–521 (2014). https://doi.org/10.1007/s10561-014-9420-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10561-014-9420-6

Keywords

Navigation